6,532 followers
New research: The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer: Pyrotinib (PYR) is a pan-HER kinase inhibitor that inhibits signaling via the RAS/RAF/MEK/MAPK and PI3K/AKT pathways. In this study, we… https://t.c